Is anemia a risk factor in pneumonia progression in covid-19-infected patients?

Basit Öğe Kaydı
dc.authoridAkçiçek, Mehmet/0000-0002-0232-1284
dc.authoridÜnlü, Serkan/0000-0001-7535-0812;
dc.authorwosidAkçiçek, Mehmet/GLN-7854-2022
dc.authorwosidÜnlü, Serkan/AAD-2212-2022
dc.authorwosidIlgar, Mehtap/GOE-4584-2022
dc.contributor.authorAkcicek, Mehmet
dc.contributor.authorIlgar, Mehtap
dc.contributor.authorUnlu, Serkan
dc.date.accessioned2024-08-04T20:59:46Z
dc.date.available2024-08-04T20:59:46Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground Determining the factors contributing to the development of severe coronavirus 2019 disease (COVID-19) disease is of great importance for health guidance. In this study, the authors aimed to investigate whether there is a relationship between anemia and progression of COVID-19 pneumonia. Patients and methods Records of 201 patients whose RT-PCR positivity for COVID-19 was confirmed between August 2020 and October 2020, when admissions and hospitalizations were at their peak, were retrospectively reviewed. The scoring system based on visual evaluation was used for evaluating the severity of the disease on each computed tomography (CT). To determine the progression status of pneumonia, the score difference was calculated by the difference between two CT scores. The patients were divided into two groups according to their hemoglobin levels as anemic and nonanemic patients. Results A significant difference was reported between the CT score difference groups in terms of mean age (P < 0.001). The mean age of the group that did not show progression was significantly lower than the other groups. Although the mean hemoglobin level of the group that did not show progression was higher than the other groups, no significant difference was reported between the groups (P=0.768). There was no significant difference between the CT score difference groups in terms of the presence or absence of anemia (P=0.791). Conclusion No significant relationship was found between hemoglobin levels, anemia, and pneumonia progression in COVID-19-infected patients.en_US
dc.identifier.doi10.4103/ecdt.ecdt_64_21
dc.identifier.endpage282en_US
dc.identifier.issn0422-7638
dc.identifier.issn2090-9950
dc.identifier.issue3en_US
dc.identifier.startpage277en_US
dc.identifier.urihttps://doi.org/10.4103/ecdt.ecdt_64_21
dc.identifier.urihttps://hdl.handle.net/11616/103508
dc.identifier.volume71en_US
dc.identifier.wosWOS:000838519900003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofEgyptian Journal of Chest Diseases and Tuberculosisen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectanemiaen_US
dc.subjectCOVID-19en_US
dc.subjectpneumoniaen_US
dc.subjecttomographyen_US
dc.titleIs anemia a risk factor in pneumonia progression in covid-19-infected patients?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu